Literature DB >> 23813153

Disseminated fusariosis secondary to neuroblastoma with fatal outcome.

Gleiciere Maia Silva1, Alice Rangel Cristiane Silveira, Claudia Abreu Rodrigues Betânia, Danielle Patrícia Cerqueira Macêdo, Rejane Pereira Neves.   

Abstract

Disseminated fusariosis is an uncommon clinical condition in immunocompromised patients. We report a fatal case of disseminated fusariosis secondary to neuroblastoma in a male patient, 15 years old, who underwent a bone marrow transplant. The patient was admitted to the pediatric intensive care unit (PICU) of a public hospital in Recife-PE, Brazil, presenting bone marrow aplasia, severe leukopenia, and thrombocytopenia. After 15 days, the patient developed right knee effusion. Synovial fluid and blood samples were analyzed at the Medical Mycology Laboratory of the Federal University of Pernambuco. Mycological diagnosis was based on the presence of hyaline septate hyphae on direct examination and the isolation of Fusarium oxysporum in culture, confirming the case of disseminated fusariosis. In vitro, the isolate showed fluconazole resistance and sensitivity to amphotericin B, anidulafungin, and voriconazole. Therapy with voriconazole in combination with liposomal amphotericin B led to an improved clinical response; however, due to underlying disease complications, the patient progressed to death.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23813153     DOI: 10.1007/s11046-013-9674-8

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  19 in total

1.  Successful treatment of stage III neuroblastoma based on prospective biologic staging: a Children's Cancer Group study.

Authors:  K K Matthay; C Perez; R C Seeger; G M Brodeur; H Shimada; J B Atkinson; C T Black; R Gerbing; G M Haase; D O Stram; P Swift; J N Lukens
Journal:  J Clin Oncol       Date:  1998-04       Impact factor: 44.544

2.  Unusual clinical features of fingernail infection by Fusarium oxysporum.

Authors:  C Gianni; A Cerri; C Crosti
Journal:  Mycoses       Date:  1997-12       Impact factor: 4.377

3.  Fusariosis associated with pathogenic fusarium species colonization of a hospital water system: a new paradigm for the epidemiology of opportunistic mold infections.

Authors:  E J Anaissie; R T Kuchar; J H Rex; A Francesconi; M Kasai; F M Müller; M Lozano-Chiu; R C Summerbell; M C Dignani; S J Chanock; T J Walsh
Journal:  Clin Infect Dis       Date:  2001-10-24       Impact factor: 9.079

4.  Mixed infection caused by two species of Fusarium in a human immunodeficiency virus-positive patient.

Authors:  J Guarro; M Nucci; T Akiti; J Gené
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

Review 5.  Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years' experience at a cancer center and implications for management.

Authors:  E I Boutati; E J Anaissie
Journal:  Blood       Date:  1997-08-01       Impact factor: 22.113

6.  Successsful voriconazole treatment of disseminated fusarium infection in an immunocompromised patient.

Authors:  Sophie Consigny; Nathalie Dhedin; Annick Datry; Sylvain Choquet; Véronique Leblond; Olivier Chosidow
Journal:  Clin Infect Dis       Date:  2003-07-09       Impact factor: 9.079

7.  Susceptibility of clinical isolates of Fusarium to antifungal drugs.

Authors:  E Speeleveld; B Gordts; H W Van Landuyt; C De Vroey; C Raes-Wuytack
Journal:  Mycoses       Date:  1996 Jan-Feb       Impact factor: 4.377

8.  Successful outcome of disseminated Fusarium infection with skin localization treated with voriconazole and amphotericin B-lipid complex in a patient with acute leukemia.

Authors:  Isabelle Durand-Joly; Serge Alfandari; Zinnédine Benchikh; Marion Rodrigue; Ana Espinel-Ingroff; Benoit Catteau; Christophe Cordevant; Daniel Camus; Eduardo Dei-Cas; Francis Bauters; Laurence Delhaes; Stéphane De Botton
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

Review 9.  Fusarium infections in immunocompromised patients.

Authors:  Marcio Nucci; Elias Anaissie
Journal:  Clin Microbiol Rev       Date:  2007-10       Impact factor: 26.132

10.  Combination therapy of disseminated Fusarium oxysporum infection with terbinafine and amphotericin B.

Authors:  A Rothe; M Seibold; Th Hoppe; H Seifert; A Engert; C Caspar; M Karthaus; G Fätkenheuer; U Bethe; K Tintelnot; O A Cornely
Journal:  Ann Hematol       Date:  2003-11-27       Impact factor: 3.673

View more
  3 in total

1.  Use of Fungal Diagnostics and Therapy in Pediatric Cancer Patients in Resource-Limited Settings.

Authors:  Sheena Mukkada; Jeannette Kirby; Nopporn Apiwattanakul; Randall T Hayden; Miguela A Caniza
Journal:  Curr Clin Microbiol Rep       Date:  2016-04-18

2.  Morphology, Phenotype, and Molecular Identification of Clinical and Environmental Fusarium solani Species Complex Isolates from Malaysia.

Authors:  Jasper E James; Jacinta Santhanam; Latiffah Zakaria; Nuraini Mamat Rusli; Mariahyati Abu Bakar; Satinee Suetrong; Jariya Sakayaroj; Mohd Fuat Abdul Razak; Erwin Lamping; Richard D Cannon
Journal:  J Fungi (Basel)       Date:  2022-08-11

3.  A 23 bp cyp51A Promoter Deletion Associated With Voriconazole Resistance in Clinical and Environmental Isolates of Neocosmospora keratoplastica.

Authors:  Jasper Elvin James; Erwin Lamping; Jacinta Santhanam; Trudy Jane Milne; Mohd Fuat Abd Razak; Latiffah Zakaria; Richard David Cannon
Journal:  Front Microbiol       Date:  2020-03-31       Impact factor: 5.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.